Author

Anastasia Grebenyuk

Observed names: A Grebenyuk, A. A. Grebenyuk, A. Grebenyuk

Observed institution: Regional Public Health Care Institution "City Hospital No. 5, Barnaul"

OpenAlex ID: A5050003056

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

2022 · Alexander P J Vlaar, Martin Witzenrath, et al. · The Lancet Respiratory Medicine · 152

Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial

2024 · Rombout B. E. van Amstel, Marleen A. Slim, et al. · Critical Care · 9

Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: a phase 3 study in critically ill, invasively mechanically ventilated COVID-19 patients

2023 · Endry H. T. Lim, Alexander P. J. Vlaar, et al. · Intensive Care Medicine Experimental · 8

Anti-C5a Vilobelimab Reduces All-cause Mortality in Critically Ill COVID-19 Patients and in Those With Severe ARDS: A Phase 3 Randomized Double-blind, Placebo-controlled Study

2023 · M. Witzenrath, A.P.J. Vlaar, et al. · 2

Vilobelimab’s effect on mortality in severe COVID-19 ARDS patients: Phase 3 RCT

2023 · Alexander Vlaar, Endry Lim, et al.

LB1529. Randomized, Controlled Phase 3 Study of anti-C5a Vilobelimab's Effect on Mortality in Critically Ill COVID-19 Patients: A Therapy for Viral Pneumonia

2022 · Bruno Mourvillier, Alexander Vlaar, et al. · Open Forum Infectious Diseases

Phase 3 RCT of C5a-Specific Vilobelimab in Severe COVID-19 Pneumonia

2022 · A P Vlaar, G Hermans, et al.

Diagnostic and treatment options for patients with COPD as part of real clinical practice. Approaches to the treatment of patients with various phenotypes according to GOLD (2019): materials of the Council of Experts of the Siberian Federal District, Chita and Buryatia, dated 03.15.19

2020 · I. V. Demko, L. M. Kudelya, et al. · PULMONOLOGIYA

Peculiarities of an ARDS and respiratory support in patients with severe viral (H1N1) pneumonia

2012 · Tatiana Martynenko, Maxim Bukchtoyarov, et al. · European Respiratory Journal

Thrombin generation test - As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis

2012 · Tatiana Martynenko, Irina Balatskaya, et al. · European Respiratory Journal

Works count: 11

Citation count: 323

H-index: 4

I10-index: 2